Theodore E Spiro

Theodore E Spiro

UNVERIFIED PROFILE

Are you Theodore E Spiro?   Register this Author

Register author
Theodore E Spiro

Theodore E Spiro

Publications by authors named "Theodore E Spiro"

Are you Theodore E Spiro?   Register this Author

9Publications

105Reads

-Profile Views

Rivaroxaban in Patients with Heart Failure, Sinus Rhythm, and Coronary Disease.

N Engl J Med 2018 10 27;379(14):1332-1342. Epub 2018 Aug 27.

From the Université de Lorraine, INSERM Unité 1116 and Clinical Investigation Center 1433, French Clinical Research Infrastructure Network, Investigation Network Initiative-Cardiovascular and Renal Clinical Trialists, Centre Hospitalier Régional et Universitaire de Nancy, Vandoeuvre lès Nancy, France (F.Z.); the Department of Cardiology and Berlin-Brandenburg Center for Regenerative Therapies, German Center for Cardiovascular Research partner site Berlin, Charité Universitätsmedizin Berlin, Berlin (S.D.A.); Janssen Research and Development, Raritan (W.M.B., C.C.N.), and Bayer U.S., Research and Development, Pharmaceuticals, Thrombosis and Hematology Therapeutic Area, Whippany (T.E.S.) - both in New Jersey; Robertson Centre for Biostatistics and Clinical Trials, University of Glasgow, Glasgow, and the National Heart and Lung Institute, Imperial College London, London - both in the United Kingdom (J.G.F.C.); Janssen Research and Development, Spring House, PA (M.F.); Northwestern University, Chicago (M.G.); National Heart Centre Singapore and Duke-National University of Singapore, Singapore (C.S.P.L.); the Department of Cardiology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands (C.S.P.L., D.J.V.); Brigham and Women's Hospital and Harvard Medical School, Boston (M.R.M.); the Division of Biostatistics, School of Public Health, University of Minnesota, Minneapolis (J.D.N.); and the Department of Medicine, Cardiology Division, University of California, San Diego, San Diego (B.G.).

View Article

Download full-text PDF

Source
http://www.nejm.org/doi/10.1056/NEJMoa1808848
Publisher Site
http://dx.doi.org/10.1056/NEJMoa1808848DOI Listing
October 2018

Rivaroxaban for Thromboprophylaxis after Hospitalization for Medical Illness.

N Engl J Med 2018 Sep 26;379(12):1118-1127. Epub 2018 Aug 26.

From the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Feinstein Institute for Medical Research, and the Department of Medicine, Anticoagulation and Clinical Thrombosis Services, Northwell Health at Lenox Hill Hospital (A.C.S.), and the Cardiovascular Institute, Mount Sinai Medical Center (J.L.H.) - all in New York; the Department of Medicine and Surgery, University of Insubria, Varese, Italy (W.A.); the Stanford Stroke Center, Stanford University Medical Center, Stanford (G.W.A.), and the University of California at Davis, Sacramento (G.A.M.) - both in California; the Department of Medicine, Intermountain Medical Center, and Department of Medicine, University of Utah, Salt Lake City (C.G.E.); Division of Cardiology, University of Colorado School of Medicine, and CPC Clinical Research, Aurora (W.R.H.); Département Hospitalo-Universitaire FIRE (Fibrose Inflammation Remodelage), University Paris Diderot, Assistance Publique-Hôpitaux de Paris, and INSERM Unité 1148, Paris (P.G.S.); Imperial College, Royal Brompton Hospital, London (P.G.S.); McMaster University and the Thrombosis and Atherosclerosis Research Institute - both in Hamilton, ON, Canada (J.I.W.); Janssen Research and Development, Raritan (E.S., E.S.B.), and the Thrombosis and Hematology Therapeutic Area, Clinical Development, Pharmaceuticals, Bayer U.S., Whippany (T.E.S.) - both in New Jersey; and the College of Public Health, University of Oklahoma Health Sciences Center, Oklahoma City (G.E.R.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1805090DOI Listing
September 2018

Predicting the risk of venous thromboembolism in patients hospitalized with heart failure.

Circulation 2014 Jul 26;130(5):410-8. Epub 2014 Jun 26.

From Université Paris Diderot, PRES Sorbonne Paris Cité and Department of Anesthesiology and Critical Care Medicine, Saint Louis Lariboisière University Hospitals, U942 Inserm, Paris, France (A.M.); Bayer HealthCare Pharmaceuticals Inc, Montville, NJ (T.E.S., Y.D.S.); Academic Medical Center, Amsterdam, The Netherlands (H.R.B.); Janssen Research & Development LLC, Raritan, NJ (L.H.); People's Hospital of Peking University, Beijing, China (D.H.); Foothills Hospital, Calgary, Alberta, Canada (R.H.); Thomas Jefferson Medical Center, Philadelphia, PA (G.M.); Dresden-Friedrichstadt Hospital, Dresden, Germany (S.W.S.); Hofstra North Shore-LIJ School of Medicine, Manhasset, NY (A.C.S.); Duke University Medical Center, Durham, NC (V.F.T.); and King's College Hospital, London, UK (A.T.C.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCULATIONAHA.113.003126DOI Listing
July 2014

Laboratory assessment of rivaroxaban: a review.

Thromb J 2013 Jul 3;11(1):11. Epub 2013 Jul 3.

Hôtel-Dieu University Hospital, 1 place du Paris Notre-Dame, Paris 75004, 4ème, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1477-9560-11-11DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3726412PMC
July 2013

Rivaroxaban for thromboprophylaxis in acutely ill medical patients.

N Engl J Med 2013 Feb;368(6):513-23

Department of Vascular Surgery, King's College Hospital, London SE5 9RS, United Kingdom.

View Article

Download full-text PDF

Source
http://www.nejm.org/doi/10.1056/NEJMoa1111096
Publisher Site
http://dx.doi.org/10.1056/NEJMoa1111096DOI Listing
February 2013

Assays for measuring rivaroxaban: their suitability and limitations.

Ther Drug Monit 2010 Dec;32(6):673-9

Division of Vascular Medicine and Haemostaseology, Department of Internal Medicine, University Hospital Frankfurt, Frankfurt, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/FTD.0b013e3181f2f264DOI Listing
December 2010